Encompass Health Corp (EHC) Operating Income (Loss) USD 2015 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Encompass Health Corp quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2022.
  • Encompass Health Corp Operating Income (Loss) for the quarter ending December 31, 2022 was $152 M, a 18.3% increase year-over-year.
  • Encompass Health Corp Operating Income (Loss) for the twelve months ending December 31, 2022 was $540 M, a 3.59% decline year-over-year.
  • Encompass Health Corp annual Operating Income (Loss) for 2022 was $540 M, a 3.59% decline from 2021.
  • Encompass Health Corp annual Operating Income (Loss) for 2021 was $560 M, a 0.76% decline from 2020.
  • Encompass Health Corp annual Operating Income (Loss) for 2020 was $564 M, a 7.88% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $540 M $152 M +$23.5 M +18.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $516 M $128 M -$13.9 M -9.83% Jul 1, 2022 Sep 30, 2022 10-K 2023-02-27
Q2 2022 $530 M $129 M -$18.2 M -12.4% Apr 1, 2022 Jun 30, 2022 10-K 2023-02-27
Q1 2022 $548 M $132 M -$11.5 M -8.04% Jan 1, 2022 Mar 31, 2022 10-K 2023-02-27
Q4 2021 $560 M $128 M -$39.9 M -23.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 $600 M $141 M -$9.7 M -6.42% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-27
Q2 2021 $609 M $147 M +$61.6 M +72.3% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-27
Q1 2021 $548 M $143 M -$16.3 M -10.2% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-27
Q4 2020 $564 M $168 M +$27.1 M +19.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 $537 M $151 M -$100 K -0.07% Jul 1, 2020 Sep 30, 2020 10-K 2021-02-26
Q2 2020 $537 M $85.2 M -$67.4 M -44.2% Apr 1, 2020 Jun 30, 2020 10-K 2021-02-26
Q1 2020 $604 M $159 M -$7.8 M -4.67% Jan 1, 2020 Mar 31, 2020 10-K 2021-02-26
Q4 2019 $612 M $141 M +$47.8 M +51.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $564 M $151 M -$3.3 M -2.14% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 $568 M $153 M -$4.7 M -2.99% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 $572 M $167 M +$17.1 M +11.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 $555 M $93.4 M -$51.3 M -35.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $607 M $155 M +$9.3 M +6.41% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $597 M $157 M +$16 M +11.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $581 M $150 M +$2.9 M +1.97% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $578 M $145 M -$800 K -0.55% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $579 M $145 M -$3 M -2.02% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $582 M $141 M -$8.9 M -5.93% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 $591 M $147 M +$2.9 M +2.01% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $588 M $146 M +$10 M +7.38% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $578 M $148 M +$27 M +22.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $551 M $150 M +$26.8 M +21.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 $524 M $144 M +$38.6 M +36.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 $486 M $136 M Oct 1, 2015 Dec 31, 2015 8-K 2017-09-19
Q3 2015 $121 M Jul 1, 2015 Sep 30, 2015 8-K 2017-09-19
Q2 2015 $123 M Apr 1, 2015 Jun 30, 2015 8-K 2017-09-19
Q1 2015 $106 M Jan 1, 2015 Mar 31, 2015 8-K 2017-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.